498 related articles for article (PubMed ID: 18425881)
1. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
[TBL] [Abstract][Full Text] [Related]
2. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Altmann ES; Crossingham I; Wilson S; Davies HR
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
[TBL] [Abstract][Full Text] [Related]
3. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2004; (2):CD002312. PubMed ID: 15106174
[TBL] [Abstract][Full Text] [Related]
4. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R
Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
[TBL] [Abstract][Full Text] [Related]
6. Surgical versus non-surgical management for pleural empyema.
Redden MD; Chin TY; van Driel ML
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010651. PubMed ID: 28304084
[TBL] [Abstract][Full Text] [Related]
7. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study.
Bouros D; Schiza S; Patsourakis G; Chalkiadakis G; Panagou P; Siafakas NM
Am J Respir Crit Care Med; 1997 Jan; 155(1):291-5. PubMed ID: 9001327
[TBL] [Abstract][Full Text] [Related]
8. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas.
Sahn SA
Thorax; 1998 Aug; 53 Suppl 2(Suppl 2):S65-72. PubMed ID: 10193351
[TBL] [Abstract][Full Text] [Related]
9. Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns.
Yigit AK; Yilmaz Y; Erdeve O; Gokce IK; Oguz SS; Uras N; Dilmen U
J Pediatr Surg; 2012 Oct; 47(10):e41-4. PubMed ID: 23084230
[TBL] [Abstract][Full Text] [Related]
10. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
Kemper P; Köhler D
Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.
Tokuda Y; Matsushima D; Stein GH; Miyagi S
Chest; 2006 Mar; 129(3):783-90. PubMed ID: 16537882
[TBL] [Abstract][Full Text] [Related]
12. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis.
Janda S; Swiston J
Chest; 2012 Aug; 142(2):401-411. PubMed ID: 22459772
[TBL] [Abstract][Full Text] [Related]
13. Parapneumonic pleural effusion and empyema.
Koegelenberg CF; Diacon AH; Bolliger CT
Respiration; 2008; 75(3):241-50. PubMed ID: 18367849
[TBL] [Abstract][Full Text] [Related]
14. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
Uyan AP; Ozyürek H; Yilmaz E
Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.
Schiza SE; Antoniou KM; Economidou FN; Siafakas NM
Pulm Pharmacol Ther; 2005; 18(6):381-9. PubMed ID: 15998594
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytics in the treatment of parapneumonic effusions.
Bouros D; Schiza S; Siafakas N
Monaldi Arch Chest Dis; 1999 Jun; 54(3):258-63. PubMed ID: 10441983
[TBL] [Abstract][Full Text] [Related]
18. A Five-Year Study of Intrapleural Fibrinolytic Therapy in Loculated Pleural Collections.
Barthwal MS; Marwah V; Chopra M; Garg Y; Tyagi R; Kishore K; Vijay A; Dutta V; Katoch CD; Singh S; Bhattacharya D
Indian J Chest Dis Allied Sci; 2016; 58(1):17-20. PubMed ID: 28368566
[TBL] [Abstract][Full Text] [Related]
19. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
